Patent · US Active

Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone

US10464923B2 · kind B2 · utility

1Cited by

0References

13Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Axel Becker · Altrip, DE
Marco Poma · Grosseto, IT
Edoardo Burini · Guidonia, IT
Christoph Saal · Otzberg, DE
Vedad Theuerkorn · Pfungstadt, DE

Key dates

Filing date	Feb 22, 2018
Grant date	Nov 5, 2019
Priority date	—
Expiry date	Feb 22, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, useful as BTK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.